EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Removal of inflammatory factors and prognosis of patients with septic shock complicated with acute kidney injury by hemodiafiltration combined with HA330‐II hemoperfusion

Juan Zhou, Haopeng Li iD, Lei Zhang, Guangjian Chen, Gang Wang, HuiHui Zhu, Yingxin Hao, Gang Wu

Therapeutic Apheresis and Dialysis · 2024

DOI: 10.1111/1744-9987.14108 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Therapeutic Apheresis and Dialysis, 2024. Verfasst von Juan Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of ICU, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Shock, Septic, Hemoperfusion, Hemodiafiltration, Acute Kidney Injury. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Clinical study of CRRT to improve outcome in patients with urosepsis and acute kidney injury.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

To explore the effect of CRRT using CVVHDF + HP on the removal of inflammatory mediators in patients with septic shock complicated with AKI.

Methods

A total of 20 patients between January 1, 2018, and December 31, 2021, were included. The patients were randomly divided into the treatment group (CVVHDF + HP) and the control group (CVVHDF). Changes in inflammatory factors, including IL‐1β, IL‐6, IL‐8, TNF‐α, PCT, and CRP were compared. Other observed measures were also analyzed, for example, Lac, Scr, BUN, SOFA, and norepinephrine (NE) dosage. The clinical outcomes of both groups were followed up for 28 days.

Results

The IL‐6 and PCT levels in the treatment group were significantly lower ( p = 0.005, 0.007). Although the IL‐1β, TNFα, and CRP levels in the treatment group decreased, there were no statistical differences ( p > 0.05). There were significant differences in Lac, SOFA, and NE dosage levels between both groups ( p = 0.023, 0.01, 0.023). Survival analysis showed that the 28‐day survival rate was significantly higher in the treatment group.

Conclusion

CRRT using CVVHDF+HP can effectively remove inflammatory factors and improve the prognosis of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shock, SepticHemoperfusionHemodiafiltrationAcute Kidney InjuryHumansMaleFemalePrognosisMiddle AgedAgedInflammation Mediators

Stichwörter der Autor:innen

acute kidney injuryhemodiafiltrationhemoperfusionseptic shock

Substanzen

Inflammation Mediators

Autor:innen und Institutionen

  • Department of ICU, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.

ORCID-Profile: Haopeng Li

Förderung

  • Clinical study of CRRT to improve outcome in patients with urosepsis and acute kidney injury

Zitieren

APA

Zhou, J., Li, H., Zhang, L., Chen, G., Wang, G., Zhu, H., Hao, Y., & Wu, G. (2024). Removal of inflammatory factors and prognosis of patients with septic shock complicated with acute kidney injury by hemodiafiltration combined with HA330‐II hemoperfusion. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14108

Vancouver

Zhou J, Li H, Zhang L, Chen G, Wang G, Zhu H, et al. Removal of inflammatory factors and prognosis of patients with septic shock complicated with acute kidney injury by hemodiafiltration combined with HA330‐II hemoperfusion. Therapeutic Apheresis and Dialysis. 2024. doi:10.1111/1744-9987.14108

BibTeX
@article{Zhou2024,
  author = {Zhou, Juan and Li, Haopeng and Zhang, Lei and Chen, Guangjian and Wang, Gang and Zhu, HuiHui and Hao, Yingxin and Wu, Gang},
  title = {Removal of inflammatory factors and prognosis of patients with septic shock complicated with acute kidney injury by hemodiafiltration combined with HA330‐II hemoperfusion},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2024},
  doi = {10.1111/1744-9987.14108}
}
Kostenlos starten →